26 results
COVAX
Spotlights of key learnings for the future pandemic preparedness and response,Spotlights of key learnings for the future pandemic preparedness and response
International Vaccine Access Center
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
International Vaccine Access Center
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
Шаблон плана развертывания операционной системы.
Руководство по оперативному развертыванию для стран.
Gemma Huckerby, Denise Habimana, Alan Brooks
Gavi, the Vaccine Alliance is a global public-private partnership with the goal of supporting the national governments of low-income countries in their efforts to increase equal access to vaccines....
International Vaccine Access Center
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
Chaevia Clendinen et al.
Nearly all of the 500,000 new cases of cervical cancer and 270,000 deaths occur in middle or lower income countries. Yet the two most prevalent HPV vaccines are unaffordable to most. Even prices to...
Gavi, the Vaccine Alliance
Since 2011, a five-year strategy has guided Gavi’s mission to save children’s lives and protect people’s health by increasing access to immunisation. In this edition of its Annual Progress...
World Health Organization (WHO)
Technet was relaunched at the 2001 conference as Technet21. The New Delhi 2001 meeting, organized back-to-back with SIGN, welcomed a total of 107 participants including 23 participants representing...
Wesolowski A et al.
Few countries in Africa currently include rubella-containing vaccination (RCV) in their immunization schedule. The Global Alliance for Vaccines Initiative (GAVI) recently opened a funding window that...
Katerini T. Storeng
Lauded for getting specific health issues onto national and international agendas and for their potential to improve value for money and outcomes, public-private global health initiatives (GHIs) have...
Gavi, the Vaccine Alliance
This evaluation assesses the extent to which the Advanced Market Commitment (AMC) pilot has achieved its stated objectives and the overarching goal to “reduce morbidity and mortality from...
Gavi, the Vaccine Alliance
This report presents the findings of the Outcomes and Impact evaluation for the Pilot Advance Market Commitment (AMC) for Pneumococcal Vaccines. This evaluation was conducted in 2015 by The Boston...
Miloud Kaddar et al.
Middle-income countries (MICs) as a group are not only characterized by a wide range of gross national income (GNI) per capita (US $1026 to $12,475), but also by diversity in size, geography,...
MCHIP
Over the past several years, the development of new vaccines, along with global efforts to make them more available and affordable, has resulted in the introduction of lifesaving vaccines in...
COVAX
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX...
PATH, University of Zambia, Infectious Diseases Research Collaboration (IDRC), Universidade Eduardo Mondlane, Health Alliance International, Gavi, the Vaccine Alliance
The Gavi Full Country Evaluations was a prospective study from 2013 to 2016 in four countries: Bangladesh, Mozambique, Uganda, and Zambia. The study aimed to understand and quantify the barriers and...